Literature DB >> 2557310

Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations.

E C Halperin1, G Bentel, E R Heinz, P C Burger.   

Abstract

In a previous study of the brains of 15 adults with glioblastoma multiforme who received minimal or no radiotherapy we determined the topographic distribution of tumor cells. All 15 brains had been fixed and then cut in the coronal or horizontal plane. The distribution of neoplastic cells was determined and entered onto tracings of the whole mount histologic sections. The last CT scans obtained prior to death of 11 of the patients were reviewed independently by a neuroradiologist who traced, on the CT scans, the outer edge of both the contrast-enhancing area and the peritumoral low density "edema". Presented with the neuroradiologist's assessment of the contrast enhancing rim of tumor and of the "edema", a radiotherapist and a radiation dosimetrist, in the present study, prepared treatment plans for a 6 MeV linear accelerator. In 9 of the 11 cases in which immediately antemortum CT scans were available, radiation treatment of the contrast enhancing area alone with a 1 cm margin would have missed portions of the histologically identified tumor. Treatment of the contrast enhancing area along with the peritumoral "edema", with a 1 cm margin, would have covered histologically identified tumor in six of the 11 cases. Treatment of the contrast enhancing area, all "edema", and a 3 cm margin around the "edema" would have covered histologically identified tumor in all cases. Tumors tended to track along nerve pathways. In those lesions near the midline it was common for tumor to cross the corpus callosum. We conclude that radiotherapy with fields designed to treat the contrast enhancing region alone or this region plus "edema" with a tight margin will frequently miss tumor which can be histologically identified by our technique.

Entities:  

Mesh:

Year:  1989        PMID: 2557310     DOI: 10.1016/0360-3016(89)90548-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  39 in total

1.  Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.

Authors:  P Farace; M G Giri; G Meliadò; D Amelio; L Widesott; G K Ricciardi; S Dall'Oglio; A Rizzotti; A Sbarbati; A Beltramello; S Maluta; M Amichetti
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

Review 2.  Management of GBM: a problem of local recurrence.

Authors:  John P Kirkpatrick; Nadia N Laack; Helen A Shih; Vinai Gondi
Journal:  J Neurooncol       Date:  2017-04-04       Impact factor: 4.130

3.  Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.

Authors:  Jana Lipkova; Panagiotis Angelikopoulos; Stephen Wu; Esther Alberts; Benedikt Wiestler; Christian Diehl; Christine Preibisch; Thomas Pyka; Stephanie E Combs; Panagiotis Hadjidoukas; Koen Van Leemput; Petros Koumoutsakos; John Lowengrub; Bjoern Menze
Journal:  IEEE Trans Med Imaging       Date:  2019-02-27       Impact factor: 10.048

4.  Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Authors:  J Sherriff; J Tamangani; L Senthil; G Cruickshank; D Spooner; B Jones; C Brookes; P Sanghera
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

5.  Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.

Authors:  Hong Rye Kim; Se-Hwan Kim; Jung-Il Lee; Ho Jun Seol; Do-Hyun Nam; Sung Tae Kim; Kwan Park; Jong Hyun Kim; Doo-Sik Kong
Journal:  J Neurooncol       Date:  2014-12-09       Impact factor: 4.130

Review 6.  The spectrum of vaccine therapies for patients with glioblastoma multiforme.

Authors:  Laura K Aguilar; Mariel Arvizu; Estuardo Aguilar-Cordova; E Antonio Chiocca
Journal:  Curr Treat Options Oncol       Date:  2012-12

7.  Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.

Authors:  Norbert Galldiks; Roland Ullrich; Michael Schroeter; Gereon R Fink; Andreas H Jacobs; Lutz W Kracht
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

8.  Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography.

Authors:  A Fiorentino; R Caivano; P Pedicini; V Fusco
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

9.  Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.

Authors:  Anna K Paulsson; Kevin P McMullen; Ann M Peiffer; William H Hinson; William T Kearns; Annette J Johnson; Glenn J Lesser; Thomas L Ellis; Stephen B Tatter; Waldemar Debinski; Edward G Shaw; Michael D Chan
Journal:  Am J Clin Oncol       Date:  2014-04       Impact factor: 2.339

10.  Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.

Authors:  Bronwyn Stall; Leor Zach; Holly Ning; John Ondos; Barbara Arora; Uma Shankavaram; Robert W Miller; Deborah Citrin; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2010-01-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.